Lisata Therapeutics, Inc. Profile Avatar - Palmy Investing

Lisata Therapeutics, Inc.

Lisata Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient …

Biotechnology
US, Basking Ridge [HQ]

Risk Factors

By Management
Not Available

    No Risk Factor available yet. You can request "Risk Factors" through an email.

End of LSTA's Analysis
CIK: - CUSIP: 128058302 ISIN: US1280583022 LEI: - UEI: -
Secondary Listings
LSTA has no secondary listings inside our databases.